Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study

Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study

Aim. To evaluate the efficacy and safety of intravenous methylprednisolone (MP) 500 mg in patients with active ankylosing spondylitis (AS) and the inefficiency, intolerability of or contraindications to treatment with 2 or more non-steroidal anti-inflammatory drugs (NSAIDs). Subjects and methods. Th...

Full description

Bibliographic Details
Main Authors: I Z Gaydukova, A P Rebrov, D A Poddubnyi
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2015-05-01
Series:Терапевтический архив
Subjects:
ankylosing spondylitis
bechterew’s disease
methylprednisolone
pulse therapy
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31738

Similar Items

Similar Items